Telogen effluvium is a common form of temporary hair loss that typically occurs after stress, a shock, or a traumatic event. It is characterized by the shedding of hair, which is often noticeable as thinning or diffuse hair loss across the scalp. This condition is part of the hair growth cycle, specifically affecting the telogen phase, which is the resting stage of hair growth.

To understand telogen effluvium, it’s essential to grasp the basics of the hair growth cycle, which consists of three phases: anagen (growth phase), catagen (transitional phase), and telogen (resting phase). Normally, about 85-90% of hair follicles are in the anagen phase, while only 10-15% are in the telogen phase. However, in telogen effluvium, a larger number of hair follicles prematurely enter the telogen phase, leading to increased hair shedding.

The condition can be triggered by various factors, including physical or emotional stress, major surgery, severe infections, chronic illness, hormonal changes (such as those occurring postpartum or with thyroid imbalances), nutritional deficiencies, and certain medications. The stressor causes a disruption in the normal hair cycle, pushing more hairs into the telogen phase, which results in noticeable hair loss approximately two to three months after the triggering event.

Telogen effluvium is usually self-limiting, meaning it resolves on its own once the underlying cause is addressed or the body adjusts to the stressor. Hair typically regrows within six to nine months, although in some cases, it may take longer. Chronic telogen effluvium, a less common form, can persist for several years and may require medical intervention to identify and treat underlying causes.

Diagnosis of telogen effluvium is primarily clinical, based on the patient’s history and physical examination. Dermatologists may perform a hair pull test, where a gentle tug on the hair reveals an increased number of hairs in the telogen phase. In some cases, a scalp biopsy or blood tests may be conducted to rule out other causes of hair loss, such as alopecia areata or nutritional deficiencies.

Management of telogen effluvium focuses on identifying and mitigating the underlying cause. Stress reduction techniques, nutritional support, and addressing any medical conditions are crucial steps. Patients are often reassured that the condition is temporary and that hair regrowth is expected once the precipitating factor is resolved.

In summary, telogen effluvium is a temporary hair loss condition linked to stress or systemic changes, characterized by an increased number of hairs entering the resting phase of the hair cycle. Understanding its triggers and natural course is essential for effective management and reassurance of affected individuals.